These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36041468)
1. Outcome of Inducing Labor in Pregnancies with Suspected Fetal Growth Restriction: Oxytocin Discontinuation during the Active Phase of Labor versus Conventional Management. Iwai S; Mimura K; Endo M; Kawanishi Y; Miyake T; Hiramatsu K; Kimura T; Tomimatsu T; Kimura T Am J Perinatol; 2024 May; 41(S 01):e739-e746. PubMed ID: 36041468 [TBL] [Abstract][Full Text] [Related]
2. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis. Saccone G; Ciardulli A; Baxter JK; Quiñones JN; Diven LC; Pinar B; Maruotti GM; Martinelli P; Berghella V Obstet Gynecol; 2017 Nov; 130(5):1090-1096. PubMed ID: 29016497 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of intravenous oxytocin in the active phase of induced labour. Boie S; Glavind J; Velu AV; Mol BWJ; Uldbjerg N; de Graaf I; Thornton JG; Bor P; Bakker JJ Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012274. PubMed ID: 30125998 [TBL] [Abstract][Full Text] [Related]
4. Discontinuation of oxytocin in the active phase of labor. Girard B; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M Acta Obstet Gynecol Scand; 2009; 88(2):172-7. PubMed ID: 19169930 [TBL] [Abstract][Full Text] [Related]
5. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial. Bor P; Ledertoug S; Boie S; Knoblauch NO; Stornes I BJOG; 2016 Jan; 123(1):129-35. PubMed ID: 26309128 [TBL] [Abstract][Full Text] [Related]
6. Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY. Girault A; Goffinet F; Le Ray C; BMC Pregnancy Childbirth; 2020 Oct; 20(1):640. PubMed ID: 33081758 [TBL] [Abstract][Full Text] [Related]
7. Oxytocin discontinuation after the active phase of labor is established. Vlachos DE; Pergialiotis V; Papantoniou N; Trompoukis S; Vlachos GD J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1421-7. PubMed ID: 25142107 [TBL] [Abstract][Full Text] [Related]
8. Misoprostol with balloon vs oxytocin with balloon in high-risk pregnancy induction: a randomized controlled trial. Al-Hafez L; Khanuja K; Mendez-Figueroa H; Al-Kouatly HB; Mascio DD; Chauhan SP; Berghella V Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101175. PubMed ID: 37806650 [TBL] [Abstract][Full Text] [Related]
9. Discontinuation of Oxytocin in the Second Stage of Labor and its Association with Postpartum Hemorrhage. MacGregor C; Plunkett B; Adams M; Silver R Am J Perinatol; 2024 Jun; 41(8):1050-1054. PubMed ID: 35240702 [TBL] [Abstract][Full Text] [Related]
10. CONDISOX- continued versus discontinued oxytocin stimulation of induced labour in a double-blind randomised controlled trial. Boie S; Glavind J; Uldbjerg N; Bakker JJH; van der Post JAM; Steer PJ; Bor P BMC Pregnancy Childbirth; 2019 Sep; 19(1):320. PubMed ID: 31477047 [TBL] [Abstract][Full Text] [Related]
11. Mode of delivery in pregnancies with suspected fetal growth restriction following induction of labor with vaginal prostaglandin E2. Ben-Haroush A; Yogev Y; Glickman H; Kaplan B; Hod M; Bar J Acta Obstet Gynecol Scand; 2004 Jan; 83(1):52-7. PubMed ID: 14678086 [TBL] [Abstract][Full Text] [Related]
12. Impact of recommended changes in labor management for prevention of the primary cesarean delivery. Thuillier C; Roy S; Peyronnet V; Quibel T; Nlandu A; Rozenberg P Am J Obstet Gynecol; 2018 Mar; 218(3):341.e1-341.e9. PubMed ID: 29291413 [TBL] [Abstract][Full Text] [Related]
13. Maternal and neonatal outcomes of pregnancies complicated by late fetal growth restriction undergoing induction of labor with dinoprostone compared with cervical balloon: A retrospective, international study. Di Mascio D; Villalain C; Rizzo G; Morales‐Rosello J; Sileo FG; Maruotti GM; Prefumo F; Galindo A; D'Antonio F; Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1313-1321. PubMed ID: 33792924 [TBL] [Abstract][Full Text] [Related]
14. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial. Wei RM; Bounthavong M; Hill MG Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100627. PubMed ID: 35358738 [TBL] [Abstract][Full Text] [Related]
16. Cervical ripening by prostaglandin E2 in patients with a previous cesarean section. Bouchghoul H; Zeino S; Houllier M; Senat MV J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101699. PubMed ID: 32018044 [TBL] [Abstract][Full Text] [Related]
17. Oxytocin discontinuation after the active phase of induced labor: A systematic review. Hernández-Martínez A; Arias-Arias A; Morandeira-Rivas A; Pascual-Pedreño AI; Ortiz-Molina EJ; Rodriguez-Almagro J Women Birth; 2019 Apr; 32(2):112-118. PubMed ID: 30087073 [TBL] [Abstract][Full Text] [Related]
18. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Wing DA; Paul RH Am J Obstet Gynecol; 1998 Jul; 179(1):94-9. PubMed ID: 9704771 [TBL] [Abstract][Full Text] [Related]
19. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: A French retrospective study. Vecchioli E; Cordier AG; Chantry A; Benachi A; Monier I PLoS One; 2020; 15(8):e0237132. PubMed ID: 32764773 [TBL] [Abstract][Full Text] [Related]
20. Balloon catheter vs oxytocin alone for induction of labor in women with a previous cesarean section: A randomized controlled trial. Sarreau M; Isly H; Poulain P; Fontaine B; Morel O; Villemonteix P; Mares P; Mousty E; Godard A; Ragot S; Pierre F Acta Obstet Gynecol Scand; 2020 Feb; 99(2):259-266. PubMed ID: 31432510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]